M10.259 Drug-induced gout, unspecified hip

Name of the Condition

• Common Name: Drug-induced gout, unspecified hip
• Technical Term: Drug-induced arthropathy affecting the hip

Summary

Drug-induced gout is a form of inflammatory arthritis caused by medications that elevate uric acid levels, leading to urate crystal deposition in joints. This results in acute inflammation and pain, specifically affecting the hip joint in this case.

Causes

This condition arises from medications that increase uric acid production or reduce its excretion. Common triggers include diuretics, immunosuppressants, low-dose aspirin, and certain chemotherapy agents. The elevated uric acid promotes crystal formation in synovial fluid, triggering an inflammatory response in the hip joint.

Risk Factors

• Use of medications known to raise uric acid levels
• Pre-existing hyperuricemia or gout history
• Renal impairment (reduced uric acid excretion)
• Dehydration or high-purine diets (exacerbating uric acid buildup)

Symptoms

• Sudden, severe hip pain (often nocturnal)
• Swelling, redness, and warmth in the hip joint
• Limited range of motion in the hip
• Tenderness to touch
• Fever (in severe cases)

Diagnosis

Diagnosis involves a physical exam of the inflamed hip joint, blood tests for uric acid levels, and joint fluid analysis to detect urate crystals. Imaging (e.g., X-rays, ultrasound) may assess joint damage, while medication history confirms the drug-induced etiology.

Treatment Options

Treatment focuses on relieving acute symptoms and addressing the underlying cause. Nonsteroidal anti-inflammatory drugs (NSAIDs) or colchicine may reduce inflammation and pain. Stopping the offending medication, if possible, is critical. Urate-lowering therapies (e.g., allopurinol) may be considered for long-term management. Joint aspiration can alleviate pressure and provide fluid for analysis.

Prognosis and Follow-Up

With appropriate treatment, symptoms often resolve within days to weeks. However, recurrent episodes or persistent joint damage may occur if the causative medication is not discontinued or if uric acid levels remain elevated. Regular follow-up monitors uric acid levels and joint function to prevent complications.

Complications

Untreated or recurrent drug-induced gout can lead to chronic joint damage, tophi (urate crystal deposits), or persistent pain. Severe inflammation may cause limited mobility or secondary infections. Long-term hyperuricemia increases the risk of kidney stones or renal impairment.

Lifestyle & Prevention

Avoiding medications known to raise uric acid levels, when feasible, is key. Staying hydrated and limiting high-purine foods (e.g., red meat, seafood) may help manage uric acid levels. Maintaining a healthy weight and avoiding alcohol can reduce gout risk. Discussing medication alternatives with a healthcare provider is important for those at risk.

When to Seek Professional Help

Seek care if hip pain is severe, sudden, or accompanied by swelling, redness, or fever. Persistent symptoms after initial treatment or recurrent episodes warrant medical evaluation. Prompt attention is necessary to prevent joint damage or complications.

Tips for Medical Coders

Document the specific hip involvement (unspecified) and confirm the drug-induced etiology. Ensure the medical record supports the diagnosis with details on the causative medication, joint symptoms, and diagnostic findings. Code M10.259 is appropriate when the hip is affected but not specified as left or right.